A little over 14 years ago, I was daydreaming in the lab. I should have been processing cancer-prone mice and recording the location of their
Dr. Joshua L. Santarpia is the Research Director for Chem/Bio programs at the National Strategic Research Institute. He is also associate professor of microbiology & pathology and program director for the biodefense and health security graduate programs at the University of Nebraska Medical Center.
Dr. Santarpia’s work is aimed at understanding and countering threats from biological organisms, especially those that pose a threat when dispersed in aerosols. He’s worked extensively on biological sensors for both the Department of Defense & Department of Homeland Security. Much of Dr. Santarpia’s current work involves understanding the factors related to aerosol/airborne transmission of the SARS-CoV-2 virus.
Dr. Santarpia has held past positions at Edgewood Chemical and Biological Center and Johns Hopkins University Applied Physics Laboratory. He was most recently a distinguished staff member at Sandia National Laboratories.
Dr. Santarpia is trained in aerosol physics and microbiology. His peer reviewed research focuses largely on the detection of biological aerosols in the environment.
Poppy Scientific Advisor
Dr. Charles Chiu, M.D./Ph.D. is a Professor of Laboratory Medicine and Dept. of Medicine, Infectious Diseases at University of California, San Francisco, Director of the UCSF-Abbott Viral Diagnostics and Discovery Center (VDDC), Associate Director of the UCSF Clinical Microbiology Laboratory, and an advisor to Poppy. He heads a translational research lab engaged in next-generation sequencing assay development for diagnosis of infectious diseases, pathogen discovery, bioinformatics software development, nanopore sequencing, and characterization of emerging infections. He has authored more than 50 peer-reviewed publications and holds over 15 patents.
Co-Chief Executive Officer
An entrepreneur and innovative scientist, Sam Molyneux is co-CEO and co-founder of Poppy. Prior to co-founding Poppy, Sam was an executive at Chan Zuckerberg, and CEO and co-founder of Meta. Sam is an experienced entrepreneur and scientist specializing in bringing mission-driven, science-forward ventures to market. Recently he’s been recognized as Canada’s Top 40 Under 40, and one of Fast Company’s Most Creative People in Business. Sam’s research has been published in Nature Genetics, Science Translational Medicine, Cancer Cell and other leading journals, and he is a frequent speaker on the future of innovation, and science-based technology for good.
Head of Innovation
A scientist and innovator, Daniela Bezdan is Head of Innovation (former Chief Scientific Officer) and co-founder of Poppy. As one of the world’s foremost authorities on metagenomics, next generation sequencing and environmental microbiomes, Dani has established best-in-class protocols and led global projects understanding indoor spaces, from subways to the International Space Station. Dani’s research is published in leading journals, and she’s a member of Germany’s COVID-19 Task Force, co-chair of NASA GeneLab’s Microbiome group, and the former Executive Director of MetaSub. Daniela is frequently consulted by industry-leading science technology companies for her expertise.